Monday, 3 February 2020

Acoustic Neuroma Market Therapeutics in Global Markets to 2023 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

The global acoustic neuroma market is growing pervasively, mainly due to the rising prevalence of the condition. There are several proven, effective therapeutics and devices to treat acoustic neuroma are available in the market, which is a major factor driving the growth of the market. Indeed, technological advancements transpired in medical science and biotechnology is a key driving force behind the growth of the market, improving the outlook for the treatments.
According to a leading research firm - Market Research Future (MRFR), the global acoustic neuroma market size is expected to garner massive accruals by 2023. In its recently published analysis, MRFR also asserts that the market would register a CAGR of approximately 7.6% throughout the forecast period (2017-2023).  Improving economic conditions are playing a pivotal role in the growth of the market, increasing the purchasing power of people, and access to quality healthcare.
Factors such as increasing per capita health care expenditures, governmental initiatives, spreading awareness towards the availability of novel treatment procedures to manage the condition are substantiating the growth of the market. Rising demand for new techniques for the diagnosis and advancements in surgical procedures fuel the growth of the market. 
Conversely, the high cost associated with the treatment & devices, alongside, the long approval time for the clinical trials are obstructing the growth of the market. Nevertheless, factors such as the large unmet needs especially in the developing regions would support the market growth over the assessment period, providing ample scope to the market to evolve further and prompting substantial investments for R&D to bring more novelty and betterments in the imaging techniques.
Global Acoustic Neuroma Market – Segments
The report is segmented into six market dynamics to widen the scope of understanding,
By Type                : Unilateral Vestibular Schwannomas and Bilateral Vestibular Schwannomas.
By Diagnosis      : Hearing Test (audiometry), Electronystagmography, and Magnetic Resonance Imaging (MRI), among others.
By Treatment    : Monitoring, Surgery, Radiation Therapy, and Supportive Therapy, among others.
By Drug Class     : Anticonvulsants, Corticosteroids, Osmotic Diuretics, and Pain Killers, among others.
By End-user                        : Hospitals, Diagnostic Centers, and Academic & Research Institutes, among others.
By Regions                          : Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global Acoustic Neuroma Market – Geographical Analysis
North America dominates the global acoustic neuroma market with the largest market share. The presence of large numbers of notable players and diagnostic centers alongside, greater governmental emphasis on disease prevention & wellness foster the regional market growth. Moreover, substantial investments in R&D activities to develop novel therapies and breakthrough medicines drive the growth of the regional market.
Healthcare facilities in the US are gradually moving from treatments to wellness; as a result, the prevention and early detection of the disease become crucial. The US acoustic neuroma market, heading with the increasing diagnosed cases accounts for the largest share in the regional market. The rising prevalence of acoustic neuroma lifestyle fosters the market growth in the region.
The acoustic neuroma market in the European region is another lucrative market. Increasing numbers of cases alongside, the proliferation of advanced treatment facilities and availability of skilled medical professionals drive the market in the region. Moreover, the increasing government support for research & development, technological advancements, and well-spread awareness among people towards the availability of treatments for the condition support the regional market growth.
The Asia Pacific acoustic neuroma market is emerging as a rapidly growing market, globally. Factors substantiating the growth of the regional market include the increasing prevalence of acoustic neuroma, spreading awareness among people about the conditions, and the availability of new treatments to manage the condition. Growing markets in China and India contribute to the regional market growth majorly.
Global Acoustic Neuroma Market – Competitive Landscape
Fiercely competitive, the acoustic neuroma market appears to be fragmented due to the presence of many well-established players. These players, along with small players and new entrants, form a competitive edge in the market. To gain a competitive advantage in the market, these players incorporating strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product/technology launch. Substantial investments are transpired in R&D to bring innovations in the therapy and clinical trials.
Major Players:
Players leading the global acoustic neuroma market include Siemens Healthcare (US), GE Healthcare (US), Philips Healthcare (US), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), F. Hoffmann-La Roche AG (Switzerland), Novartis AG (Switzerland), Merck & Co., Inc. (US), and Pfizer Inc. (US), among others.
Industry/ Innovation/Related News:
July 22, 2019 ----- Med-El Corporation (the US), a leading global medical device company specializing in the development and manufacturing of implantable hearing solutions and speech processors announced receiving of the US FDA approval for its Cochlear Implants for single-sided deafness (SSD) and asymmetric hearing loss (AHL). Cochlear implants from MED-EL are the world’s most innovative devices helping children and adults with hearing loss hear life again. This is the first time ever that cochlear implants have been approved for these indications in the United States.
Contraindications for SSD and AHL are the same as for individuals receiving cochlear implants who have bilateral hearing loss, if the individual is known to be intolerant of the materials used in the implant and if an individual has an acoustic neuroma, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Global Augmented Bone Graft Market Production, Capacity, Revenue, Price, Gross Margin Analysis and forecast 2019-2025

Overview:
Bone grafting is known as a surgical procedure that is known for its effective handling of replacing missing bone or to repair bone fracture. The process requires extremely complex handling of the technology and this poses threat to the patient. However, recent advantages in provided by various technologies are expected to deliver the augmented bone graft market a possible CAGR of 7.8% during the forecast period of 2017 to 2023. Market Research Future (MRFR) declares that the market can get traction from various aspects like the hike in better technological integration, significant changes in the market due to better financial investment, better R&D facilities and others. Also, the inclusion of polymers and ceramics can improve the market scenario. However, high investment associated with the entire procedure can hold back the market. Ethical issues can also hold back the expected augmented bone graft market trends.
Segmentation:
The study of the market for Augmented Bone Graft can be segmented into products, application, and end-users. Such a detailed analysis of the segmentation would unfurl various factors that can impact the global market in the coming years. These factors can be assessed further on the basis of figures fetched by various adept analysts.
By product, the market for Augmented Bone Graft includes Bone Grafts Substitutes, Allografts, and Cell-based Matrices. The Allografts segment contains Machined Allografts and Demineralized Bone Matrix. The Bone Grafts Substitutes covers Bone Morphogenic Proteins (BMP) and Synthetic Bone Grafts.
By application, the market for Augmented Bone Graft includes Dental, Craniomaxillofacial, Joint Reconstruction, Long Bone, Foot & Ankle, and Spinal Fusion,
By end-user, the market for Augmented Bone Graft forms around clinics, hospitals, ambulatory surgical centers, and others. the procedure is quite complex owing to which hospitals may find better growth traction.
Regional Analysis:
North America has the better market coverage owing to high inclusion of various strategic moves and high integration of infrastructural changes. Countries in the region perform better due to their high expenditure capacity and better healthcare setup. This is working mostly for countries like the US and Canada. Other countries from the regions are receiving substantial grants to impact the global market. Various countries are also implementing favorable laws to help the market grow. Europe is getting better traction due to high healthcare spending in Germany. Orthopedic biologics is expected make substantial contribution in Europe. Healthcare spending in the Western Europe is quite substantial owing to which the market flow would be better.
In Asia Pacific region, various countries are investing substantially in the market. Governments from this region are putting in various efforts to make sure that the regional market grows at a faster speed. This gets backed up substantially by countries like India and China.
In the Middle East & Africa, the market is expected to make a sluggish growth. The Middle East market sees hike in various research and development projects. Africa, on the other hand, has several countries who are poor economies where the growth would be not that great.
Competitive Landscape:
The global market for augmented bone graft has become quite competitive owing to the inclusion of several new entrants in an already well-structured market thriving with various established players. MRFR profiled these companies for a better understanding of the global market. This profiling allows easy access to the latest moves initiated by these market players. These companies are BioMimetic Therapeutics LLC, Zimmer Holdings, Inc., Stryker Corporation, Wright Medical Technology, Inc., RTI Surgical, Inc., Smith & Nephew Plc, NuVasive, Inc., Olympus Biotech Corporation, Medtronic, Inc., NovaBone Products LLC, Integra LifeSciences Holdings Corporation, LifeNet Health, Inc., Synthes Inc., Exactech, Inc., DePuy Spine, Inc., Biomet, Inc., DePuy Synthes Companies, and AlloSource.
In June 2019, researchers from the Marshall University revealed that they are working hard on a project to understand how they can reconstruct anterior cruciate ligament (ACL) by using bone marrow concentrate, amnion, and suture tape.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Healthcare Revenue Cycle Management Market Research Report 2019 Analysis and Forecast to 2027

The healthcare revenue cycle management (HRCM) market growth leaps and bounds. Considerable advancements in healthcare IT and the proliferating medical sector drive the market growth, predominantly. The aggressively increasing population years by years is prompting the demand for the highest quality, coordinated care. Besides, rising administrative & operational expenses required to keep the show running in healthcare set-ups are demanding cost-effective alternatives.
The pressure to curtail these expenses in healthcare organizations is increasing continually. As a commutative result of these, the adoption of healthcare RCM solutions has increased dramatically, over the recent years and so is rising the healthcare RCM market.  According to Market Research Future (MRFR), the global healthcare revenue cycle management market is expected to generate a valuation of USD 175,163.5 MN by 2024.
In its recently published study, MRFR also asserts that the market would register over 12 % CAGR throughout the assessment period (2017-2024). The emergence of automated revenue cycle management is a major driving force behind the enormous growth of healthcare RCM market. The viable solutions offered by RCM are widening its uptake across the globe.
With the increasing accuracy & efficiency and access to healthcare IT systems, RCM solution further allows increased revenue generation, which acts as a tailwind pushing up the market growth. Additional factors such as the rapidly developing healthcare infrastructures, growing digitization, and the augmenting demand for data integration, data quality, management, and data governance substantiate market growth.
Strong clinical network connectivity with medical practitioners is the latest trend observed in the market, which is projected to continue throughout the review period fostering the market growth.
Global HRCM Market   - Segments
The report is segmented into five market dynamics to widen the scope of understanding,
By Deployment          : On-cloud, On-premises, and Web-based, others.
By Component             : Software and Service, among others.
By Product Type         : Standalone and Integrated, among others
By End-users               : Hospitals and Ambulatory Services, among others.
By Regions                   : Asia Pacific, Europe, North America, and Rest-of-the-World.

Global Healthcare RCM Market   - Geographical Analysis
North America leads the global HRCM market with the largest market share. High per capita healthcare expenditures and well-established healthcare sectors in the region drive the growth of the regional market. Moreover, the rapid adoption of RCM solutions in increasing numbers of healthcare set-ups impacts the market growth in the region, positively. 
Favorable government policies and enhanced incentives foster the growth of the regional market. Canada and the US account for the key contributors to the regional market growth due to the successful implementations of IT solutions in their healthcare systems. The presence of well-developed healthcare infrastructures and IT sector and regulatory framework would further boost the market growth in the region. 
Europe takes the second lead in the global healthcare RCM market. Factors such as the rapid technological advancements in well-developed healthcare sectors in the region substantiate the regional market growth. Additionally, increased digitization and increasing focus on data integration, data quality, management, and data governance drive the growth in the regional market, predominantly. 
The Asia Pacific healthcare revenue cycle management market is growing briskly. Rapid technological advancements and the increasing adoption of RCM tools in healthcare facilities is leading the growth of the regional market. APAC countries such as Japan, China, and India account for the major contributors to the regional market growth due to the wide adoption of HRCM products and services.
Global Healthcare RCM Market   - Competitive Landscape
The highly competitive Healthcare RCM market appears fragmented due to the several large and small key players along with the new entrants forming a competitive landscape. Key players through strategic partnership, acquisition, expansion, collaboration, product & technology launch try to gain competitive advantage. They make substantial investments in R&D to develop a technology that is unrivaled and is entirely on a different level compared to their competition. 
Major Players: 
Players leading the global HRCM market include Epic Systems (US), General Electric Company (US), Cerner Corporation (US), Quest Diagnostics (US), McKesson Corporation (US), Allscripts (US), and Siemens Healthcare (Germany) among others.
Industry/Innovation/Related News:
September 23, 2019 --- Cerner Corporation (the US), a leading global provider of health information technology solutions, services, devices, and hardware announced its partnership with Simplee (the US), a software-as-a-service company that develops payment software for the health care industry.
The aim is to help improve patient experience through a more consumer-centric experience that lets care recipients better understand the billing process. The partnership would enable Cerner to add Simplee's financial engagement platform to its revenue cycle portfolio and incorporate its billing tools into its consumer-facing technology.
September 19, 2019 --- Zotec Partners LLC (the US), one of the largest revenue cycle management (RCM) providers announced that it has been selected to Transform the healthcare financial experience in the recently launched Walmart Health Center, a largest in-store clinic in Dallas (the US). Zotec with its end-to-end RCM technology and services, would simplify its healthcare processes and provide its customers with more access & control over their healthcare experiences, including primary care, dental, vision, and mental health services.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Surgical Equipment Market Revenue, Opportunity, Forecast and Value Chain Analysis 2019

The global surgical equipment market share is poised to grow significantly and strike a CAGR of 6.2% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an extensive study. The growth of the global surgical equipment market is stemmed from the massive rise in the volume of surgeries across the globe. Rise in the number of cardiovascular, orthopedic, ophthalmic, and neurosurgeries have generated greater demand for surgical equipment such as electrosurgical devices, surgical sutures and staples, handheld instruments, electrosurgical generators, and monitoring devices which stimulates the growth of the market. The use of advanced surgical equipment is essential for the success rate of surgeries.  In addition, the surging prevalence of chronic diseases on a global scale has been a plus for the market growth.  Innovation in design, material, and quality which can ensure longer lifecycle is also expected to boost the growth of the market. Other factors contributing to the growth of the market include the mounting number in the establishment of medical facilities in diverse geographies such as hospitals, clinics, ambulatory surgical centers, and others. On the flip side, the growth of the global surgical equipment market might be hindered by hefty costs of surgical equipment and stringent regulatory norms monitoring surgical equipment industry.
Segmentation
The global surgical equipment market has been segmented based on product type, application, and end-user.
By product type, the market global surgical equipment market has been segmented into surgical sutures and staplers, handheld instruments, electrosurgical devices, electrosurgical generators, monitoring devices, and others. The Surgical sutures and staplers segment has been further segmented into absorbable and non-absorbable sutures. The handheld instruments segment has been further segmented into forceps, sutures, visual scope, and others. The electrosurgical devices segment has been further segmented into electrosurgical instruments such as HET bipolar system, electrosurgical pencils, smoke evacuation system, electrosurgical generators, and others.
By application, the global surgical equipment market has been segmented into wound closure, neurosurgery, cardiovascular surgeries, urology, orthopedic surgery, and others.
By end-user, the global surgical equipment market is segmented into hospitals, ambulatory surgical centers, and others.
Regional Analysis
The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are the key markets for surgical equipment.
The Americas is at the forefront of the global surgical equipment market owing to the rapid expansion of the medical device industry in the region. The growing focus on quality care and the availability of technologically-advanced surgical devices also favor market growth. In addition, the presence of various key medical device manufacturers in the region and increasing volume of surgeries augments the growth of the market. Other boosting a factor include high healthcare expenditure and the rise in the prevalence of chronic diseases.
Europe too is a significant market driven by the growing presence of key medical device manufacturers in the region. High government support and favorable medical device policies support the growth of the market. Expanding healthcare spending in the developed economies of the region such as the UK and Germany are likely to foster the growth of the market.
APAC market is poised to showcase rapid growth over the forecast period driven by the ever-increasing prevalence of chronic diseases in the region and subsequent rise in surgeries. High healthcare expenditure in the developing economies of the region such as China, Japan, Australia and India are likely to catapult the growth of the market on an upward trajectory. Availability of skilled healthcare professionals also acts as a plus for the growth of the market.
The MEA market is spurred by increasing healthcare expenditure in the Gulf nations and growing demand for primary care services in the Africa region.
Competitive Landscape
The eminent players in the global surgical equipment market include Synergetics USA, Inc. (US), KLS Martin (Germany), Erbe Elektromedizin GmbH (Germany), B. Braun Melsungen AG (Germany), KARL STORZ & Co. (US), Smith & Nephew (UK), Ethicon US, LLC. (US), Stryker Corporation (US), CONMED Corporation (US), MEDICON (US), Integra LifeSciences Corporation (US), and COVIDIEN (US).
Industry Updates
November 2018- BandGrip, a company focused on innovation of wound closure devices, introduced the Micro-Anchor Skin Closures, a wound closure device for better healing results. The new device is based on micro anchor technology which facilitates better grip compared to traditional wound closure devices.
Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com


Posted by at No comments:

Current and forthcoming Drug Allergy Market size in terms of volume and value 2019

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Drug Allergy Market Research Report - Global forecast till 2023” Gives industry size, top players and worldwide demand
Synopsis of Global Drug Allergy Market
Market Research Future (MRFR) has announced a new release on the global Drug Allergy Market. The report takes into account the Global Drug Allergy Market’s historical growth trajectory and major growth drivers and restraints in order to come up with a reliable projection for the market’s likely growth trajectory over the forecast period from 2018 to 2023.
Increasing awareness about various allergies, the introduction of the new treatment of products and rising demand from emerging markets drives the growth of the global market. Drug allergy is one of the most common types of allergies. It is the hyper sensitivity of the immune system to drug or medication. Any types of drugs such as prescription, nonprescription or herbal can induce drug allergy. Some common symptoms of the drug allergies are hives, skin rash, itching of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can relieve and prevent severe reactions.
New research to prevent drug allergies is another key driver for the market. The global drug allergy market is growing moderately and is expected to continue its growth over the forecast period.
Reaction to drugs and other medication can differ from patient to patient, with drug allergies becoming increasingly common. Market Research Future (MRFR) in its latest report has discovered that the market is due to witness a CAGR of 5.1% during the forecast period of 2017 to 2023. MRFR has further ascertained that the drug allergy market share is expected to grow to reach an estimated value of USD 4,764 Mn by the end of 2023
Top Key Players
AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.
Segments                   
The global drug allergy market is segmented on the basis of type, which comprises of immunologic, nonimmunologic, and others. Immunologic allergy is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. The non-immunologic allergy is sub-segmented into predictable, unpredictable, and others. The predictable allergy is further segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. The unpredictable segment is further sub-segmented into pseudoallergic, idiosyncratic, intolerance, and others.
On the basis of diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. The skin test is further segmented into prick or scratch test, intradermal test, and others.
On the basis of treatments, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines are further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is further sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide, and others.
On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Regional Analysis
The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.
Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.
Asia Pacific region is showing the fastest growth rate in the global drug allergy market due to some major factors such as increasing awareness about various drug allergies, availability of treatment products, and rapidly improving healthcare facilities. Japan is holding the major market share while China’s drug allergy market is expected to show the fastest growth in this region. Changing healthcare practices and increasing patient involvement play an important role in the growth of this market.
The Middle East & Africa is expected to experience a limited growth due to lack of awareness about diseases, traditional healthcare practices, etc. The Middle East region dominates the market due to some of the major factors, for instance, developed healthcare facilities and government support to improve public health.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

CBCT Dental Imaging Market Expected to Boost during 2019 To 2023

U.S., India & Europe CBCT Dental Imaging Market Information, by Type of Detector (Flat Panel Detectors, Image Intensifier), by Application (Dental Implants, Endodontics, Orthodontics and others) by End Users (Hospitals & Dental clinics, Academic & Research Institutes and others) - Forecast to 2023
Market Scenario:
Dental cone beam computed tomography (CT) is a special type of x-ray equipment used when regular dental or facial x-rays are not sufficient. The technology is used to produce three dimensional (3-D) images of the teeth, soft tissues, nerve pathways and bone in a single scan. The CBCT dental imaging industry is growing rapidly. The increasing use of 3D radiographic imaging in orthodontics and increasing adoption of CBCT imaging by dental professionals has boosted the revenue of this market. 
The U.S., India & Europe market is expected to reach USD 565.3 million by the end of the forecast period due to rising CBCT Dental Imaging Market Trends and is expected to grow at a CAGR of 9.8%.
Key Finding
  • The U.S., India & Europe CBCT dental imaging market and is expected to reach USD 565.3 million by 2023.
  • Regionally, U.S. holds the largest CBCT dental imaging market share of U.S., India & Europe CBCT dental imaging market and is expected to reach USD 280.9 million by 2023.
  • India market is expected to be the fastest growing market, and expected to grow at a CAGR of 10.3% from 2016 to 2023
Key Players for U.S., India & Europe CBCT dental imaging market:
Some of the key players in this market are: Carestream Health (US), Dentsply Sirona (US), FONA Dental, S.R.O., Gendex, Imaging Sciences International, LLC (US), J.MORITA MFG.CORP. (Japan), KaVo Dental GmbH (Germany), NewTom, Planmeca OY, Prexion (US), Sinclair Dental/Dentaire (Canada), SOREDEX (Finland), Vatech Networks (Republic of Korea) and others.
Segments:
U.S., India & Europe CBCT dental imaging market has been segmented on the basis of type of detector which comprises of flat panel detectors, image intensifier. On the basis of application the market is segmented into dental implants, endodontics, orthodontics and others. On the basis of end users the market is segmented into hospitals & dental clinics, academic & research institutes and others.
Regional Analysis of U.S., India & Europe CBCT dental imaging market:
U.S. is the largest market for CBCT Dental Imaging market. The U.S. market for CBCT dental imaging is expected to grow at a CAGR of 9.5% and is expected to reach at USD 280.9 Million by the end of the forecast period.
Europe is the second-largest market for CBCT dental imaging which is expected to grow at a CAGR of 10.0%. India region is expected to be fastest growing region in CBCT dental imaging market.
The report for U.S., India & Europe CBCT Dental Imaging Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Bioinformatics Market 2019 - Opportunity, Driving Trends and deep study 2022

Growing Government Support Crucial for Growth of Bioinformatics Market in Developing Regions
The global bioinformatics market size is expected to exhibit a CAGR of 19.8% over the forecast period from 2016 to 2022, according to a new research report from Market Research Future (MRFR). The global bioinformatics market is mainly driven by the growing demand in developing countries in enhancing their healthcare sector and making advanced healthcare modalities available to patients.
The growing demand for electronic healthcare data storage is likely to be a major driver for the global bioinformatics market. The reliance on manual and paper-based documentation of healthcare procedures has resulted in unmanageable volumes of healthcare information, which can make it difficult to locate individual patients and their medical history. Electronic healthcare records, which are but the first step of the bioinformatics market, have already become widely popular in developed countries due to the benefits they present in terms of consistent data storage over the long term and ease in acquiring specific details at any given time. The growing demand for e-prescriptions and online pharmacies is likely to further the cause of the bioinformatics market over the forecast period, as strong bioinformatics networks are needed to operate and manage e-prescriptions and the related documentation.
The growing demand for strong data storage facilities in medical research is also likely to be a major driver for the global bioinformatics market. Bioinformatics plays a key role in genetic studies, in which it helps track details regarding multiple genes and their multifarious associations with the indicators being studied in the respective trial. The growing dependence on genetic studies in cancer research is likely to be a major driver for the global bioinformatics market over the forecast period, as cancer research has received strong government backing across the world. Other medical research applications are also likely to make use of bioinformatics systems on a large scale in the coming years, leading to steady growth of the global bioinformatics market over the forecast period.
Competitive Analysis:
Leading players in the global bioinformatics market include Agilent Technologies, Qiagen N.V., Dassault Systemes, Thermo Fisher Scientific Inc., and Illumina Inc.
Segmentation:
The global bioinformatics market is segmented on the basis of application, service, sector, and region in the MRFR report in order to provide a comprehensive coverage of all important factors related to the market’s growth prospects over the forecast period.
The bioinformatics market has been segmented on the basis of application into genomics, chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics, DNA sequences, and others. Increasing interest in genetic studies is likely to be a major driver for the global bioinformatics market over the forecast period.
On the basis of services and technology, the global bioinformatics market is segmented into data warehousing, sequence analysis, sequence manipulation, and others.
On the basis of sector, the bioinformatics market is segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, and others. Medical bioinformatics is likely to dominate the global bioinformatics market over the forecast period due to the increasing government support for the use of bioinformatics modalities in clinical decision making and research.
Regional Analysis:
The global bioinformatics market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The global bioinformatics market is dominated by the Americas and Europe in terms of region due to the presence of strong telecommunications infrastructure in these regions to support advanced bioinformatics processes. The presence of a strong wireless internet and other telecommunication features is crucial for a bioinformatics system to function productively. This has actually been one of the key factors that has held back the bioinformatics market in underdeveloped regions.
In April 2019, researchers from UCLA announced a plan to develop a system that would allow scientists in developing countries to use cloud computing and big data analytics to accelerate the development of the bioinformatics field in their own countries. Efforts such as these are the result of the growing awareness of the disparity in terms of telecommunications infrastructure between developed and developing countries.
Asia Pacific is likely to exhibit the fastest growth over the forecast period due to the increasing efforts from governments in the region to incorporate powerful bioinformatics programs into the day-to-day functioning of their country’s healthcare sector. 
Posted by at No comments:
Subscribe to: Posts (Atom)